Previous 10 | Next 10 |
Osmotica Pharmaceuticals OSMT -26% on FDA response letter.Big Rock Partners Acquisition (BRPA) -25%.Regional Health Properties (RHE) -18%.Gevo (GEVO) -15%.New Concept Energy (GBR) -15%.MoSys (MOSY) -13%.Oxbridge Re Holdings (OXBR) -10%.IRIDEX (IRIX) -10%.Equillium (EQ) -10%.Tenax Th...
Gainers: [[CNFR]] +90.6%. [[IMMP]] +8.5%. [[NGL]] +4.4%. [[CHMA]] +3.8%. [[MDU]] +3.6%.Losers: [[JRJC]] -10.0%. [[GBR]] -7.4%. [[ACY]] -6.4%. [[EQ]] -4.5%. [[IRIX]] -4.1%. For further details see: CNFR, ACY, IMMP, and JRJC among after-hours movers
Gainers: Tenax Therapeutics (TENX) +132%, Regional Health Properties (RHE) +38%, IRIDEX (IRIX) +22%, INmune Bio (INMB) +17%, Mirum Pharmaceuticals (MIRM) +8%.Losers: Arcturus Therapeutics (ARCT) -53%, Actinium Pharmaceuticals (ATNM) -24%, Alpine Immune ...
Universal Security Instruments (UUU) +293%.Technical Communications (TCCO) +214%.Koss Corporation (KOSS) +99%.Tenax Therapeutics (TENX) +80%.New Concept Energy (GBR) +58%.IRIDEX Corporation (IRIX) +23%.SOS Limited (SOS) +10% after announcing partnership with Zhonglu P&C Insuranc...
Gainers: [[UUU]] +71.2%. [[IRIX]] +28.6%. [[XGN]] +10.6%. [[CANG]] +10.5%. [[MIRM]] +6.4%.Losers: [[ARCT]] -35.3%. [[ACY]] -23.3%. [[AIRT]] -8.8%. [[RHE]] -7.6%. [[RCMT]] -6.2%. For further details see: UUU, ACY, IRIX, and ARCT among after-hours movers
IRIDEX Corp ([[IRIX]] +13.1%) reports that MicroPulse Transscleral Laser Therapy ((TLT)), which is performed using the IRIDEX Cyclo G6 Laser System and MicroPulse P3 Delivery Device, has been included in the European Glaucoma Society ((EGS)) Terminology and Guidelines...
Guidelines provide recommendations on the diagnosis and management of glaucoma within the EU Nine MicroPulse TLT studies presented at the annual EGS meeting supporting its safety, effectiveness, and versatility in the treatment of glaucoma MOUNTAIN VIEW, Calif., Dec. 22,...
IRIDEX Corporation (IRIX) Q3 2020 Earnings Conference Call November 9, 2020 5:00 PM ET Company Participants Hunter Cabi – Investor Relations Dave Bruce – Chief Executive Officer Jim MacKaness – Interim Chief Financial Officer Conference Call Participants Jon Block –...
IRIDEX (IRIX): Q3 GAAP EPS of -$0.12 beats by $0.05.Revenue of $8.8M (-17.4% Y/Y) beats by $1.01M.Press Release For further details see: IRIDEX EPS beats by $0.05, beats on revenue
MOUNTAIN VIEW, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 26, 2020. Third Quarter Summary Total revenue of $8.8 million, a decline of 17% versus $10.7 million in the prior...
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company...